Sound Pharmaceuticals, Incorporated

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Sound Pharmaceuticals, Incorporated sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 2 currently recruiting 7 completed early-phase tilt top decile by trial count

Sound Pharmaceuticals, Incorporated: 9 sponsored US clinical trials, 2 recruiting.

Sound Pharmaceuticals, Incorporated sponsors 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cochlear Trauma, with 1 trials.

Top-decile sponsor footprint

Sound Pharmaceuticals, Incorporated ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

9 total, page 1 of 1

RECRUITING Phase 3

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

NCT06859788
RECRUITING Phase 2

SPI-1005 in Adults Receiving Cochlear Implant

NCT06340633
COMPLETED Phase 3

SPI-1005 for the Treatment of Meniere's Disease

NCT04677972
COMPLETED Phase 2

SPI-1005 Treatment in Severe COVID-19 Patients

NCT04483973
COMPLETED Phase 2

SPI-1005 for the Treatment of Patients With Meniere's Disease

NCT03325790
COMPLETED Phase 2

SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

NCT02819856
COMPLETED Phase 1

Study to Evaluate SPI-1005 in Adults With Meniere's Disease

NCT02603081
COMPLETED Phase 2

Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift

NCT01444846
COMPLETED Phase 1

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

NCT01452607

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 5
Phase 3 2

Therapeutic Areas

Cochlear Trauma 1
Ménière's Disease 1
Ménière 1
Meniere Disease 1
Meniere's Disease 1
Hearing Loss 1

What is open in the Sound Pharmaceuticals, Incorporated pipeline

2 recruiting of 9 indexed (22% open); 7 completed (78%).

Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Cochlear Trauma (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Sound Pharmaceuticals, Incorporated: open-pipeline peers nationwide

Peers matched on 9 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Sound Pharmaceuticals, Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 8101214161820 0%10%20%30%40%50% Total trials Recruiting share Sound Pharmaceuticals, Incorporated4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyALX OncologyBiosense WebsterEnglewood Hospital and Medical CenterEnsysce Biosciences
Sound Pharmaceuticals, Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sound Pharmaceuticals, Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Sound Pharmaceuticals, Incorporated page

9 registered trials is a research-attention snapshot, not an endorsement of Sound Pharmaceuticals, Incorporated or any single study.

  • 2 of Sound Pharmaceuticals, Incorporated's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cochlear Trauma is the condition Sound Pharmaceuticals, Incorporated studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cochlear Trauma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Sound Pharmaceuticals, Incorporated pipeline card: 9 registered trials from official public datasets.Report a data error.